Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T van Laar

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1992
Rectal apomorphine: a new treatment modality in Parkinson's diseaseT Van Laar, E N Jansen, A W Essink, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretionT van Laar, G J Lammers, R A Roos, et al.
British Journal of Clinical Pharmacology|April 22, 2016
A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticityH W Heetla, J H Proost, B H Molmans, et al.
Cytometry|September 1, 1996
Temperature-sensitive mutant p53 (ala143) interferes transiently with DNA-synthesis and cell-cycle progression in Saos-2 cellsT van Laar, R Schouten, A G Jochemsen, et al.
Journal of Virology|September 1, 1993
Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformationS J van den Heuvel, T van Laar, I The, et al.
International Journal of Bio-Medical Computing|June 1, 1994
Comparison of two software programs to be used for the calculation of population pharmacokinetic parametersC Neef, R W Jelliffe, T van Laar, et al.
Clinical Neurology and Neurosurgery|September 1, 1993
A double-blind study of the efficacy of apomorphine and its assessment in 'off'-periods in Parkinson's diseaseT van Laar, E N Jansen, A W Essink, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: a histologic studyT van Laar, B van Hilten, C Neef, et al.
Clinical Parkinsonism & Related Disorders|March 4, 2022
Radiation of parotid or submandibular glands is effective for drooling in patients with parkinsonism; a randomised double-blind placebo-controlled trialR J H M Steenbakkers, S P van Doornik, A Vissink, et al.
Biochemical and Biophysical Research Communications|December 26, 1995
GM1492 human diploid skin fibroblasts lack the p53-dependent G1 cell-cycle checkpointT van Laar, W T Steegenga, A G Jochemsen, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1992
Rectal apomorphine: a new treatment modality in Parkinson's diseaseT Van Laar, E N Jansen, A W Essink, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretionT van Laar, G J Lammers, R A Roos, et al.
British Journal of Clinical Pharmacology|April 22, 2016
A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticityH W Heetla, J H Proost, B H Molmans, et al.
Cytometry|September 1, 1996
Temperature-sensitive mutant p53 (ala143) interferes transiently with DNA-synthesis and cell-cycle progression in Saos-2 cellsT van Laar, R Schouten, A G Jochemsen, et al.
Journal of Virology|September 1, 1993
Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformationS J van den Heuvel, T van Laar, I The, et al.
International Journal of Bio-Medical Computing|June 1, 1994
Comparison of two software programs to be used for the calculation of population pharmacokinetic parametersC Neef, R W Jelliffe, T van Laar, et al.
Clinical Neurology and Neurosurgery|September 1, 1993
A double-blind study of the efficacy of apomorphine and its assessment in 'off'-periods in Parkinson's diseaseT van Laar, E N Jansen, A W Essink, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: a histologic studyT van Laar, B van Hilten, C Neef, et al.
Clinical Parkinsonism & Related Disorders|March 4, 2022
Radiation of parotid or submandibular glands is effective for drooling in patients with parkinsonism; a randomised double-blind placebo-controlled trialR J H M Steenbakkers, S P van Doornik, A Vissink, et al.
Biochemical and Biophysical Research Communications|December 26, 1995
GM1492 human diploid skin fibroblasts lack the p53-dependent G1 cell-cycle checkpointT van Laar, W T Steegenga, A G Jochemsen, et al.
Pageof 7